National Accreditation Board Suspends All DNA Testing at D.C. Crime Lab
By Keith L. Alexander,
Washington Post
| 04. 27. 2015
Untitled Document
One of the national organizations that govern DNA laboratories has ordered the District’s new crime lab to immediately suspend all DNA casework after concluding that the lab’s procedures are “insufficient and inadequate.”
D.C. Mayor Muriel E. Bowser ordered the audit by the ANSI-ASQ National Accreditation Board last month after the U.S. attorney’s office said it had discovered numerous errors in some of the lab’s DNA analyses. The audit, which was published Friday, criticized the lab’s practices and said they were not in compliance with FBI standards. It ordered “at a minimum” the revalidation of test procedures, new interpretation guidelines for DNA mixture cases, additional training and competency testing of staff.
The DNA analysts at the District’s Department of Forensic Sciences, according to the audit, “were not competent and were using inadequate procedures.” The authors of the review said the lab must begin to address the concerns within 30 days.
Legal experts say the audit could trigger a further investigation of hundreds of District criminal cases — including murder, sexual assault and gun possession cases — that have involved...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
